Analysts are confident about the athleisure company's upcoming results, but less sure about its long-term prospects.

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Morgan Stanley analysts maintained an Overweight rating on Trip.com Group Limited (NASDAQ:TCOM), while raising the price ...

A recession usually spells trouble for corporate profits and consumer spending, but Morgan Stanley sees a downturn as a ...

Morgan Stanley lifted NVIDIA Corporation (NASDAQ:NVDA)’s stock price target to $170 from $160, while maintaining an ...

On Thursday, Morgan Stanley analysts adjusted their outlook on e.l.f. Beauty (NYSE: ELF) shares, raising the price target significantly from $70.00 to $105.00, while keeping their rating at ...

Morgan Stanley has reduced its price target on The Campbell’s Company (NASDAQ:CPB) to $35 from $40, maintaining an Equal ...

On Monday, Morgan Stanley analysts raised the price target for LuxExperience (NYSE: LUXE) stock to $10 from a previous target of $4, with the stock currently trading at $9.35.

Any lapse in Swiggy’s execution could erode its market share across both food delivery and quick commerce segments, Morgan ...

In the recent equity strategy note, Morgan Stanley set a 50% chance of Sensex hitting 89,000 (base case scenario) considering ...